Institutional investors including Vanguard, BlackRock, State Street
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$843.0B
Focus Areas
10
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Eli Lilly | $811.5B |
| Agilent Technologies | $31.5B |